The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims ...

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.

The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.